DARE
Price:
$1.16
Market Cap:
$11.05M
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation...[Read more]
Industry
Biotechnology
IPO Date
2014-04-10
Stock Exchange
NASDAQ
Ticker
DARE
According to Dare Bioscience, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.22. This represents a change of -52.27% compared to the average of -2.56 of the last 4 quarters.
The mean historical PE Ratio of Dare Bioscience, Inc. over the last ten years is -3.04. The current -1.22 PE Ratio has changed 3.91% with respect to the historical average. Over the past ten years (40 quarters), DARE's PE Ratio was at its highest in in the June 2022 quarter at 62.86. The PE Ratio was at its lowest in in the September 2016 quarter at -130.88.
Average
-3.04
Median
-1.94
Minimum
-7.29
Maximum
-0.28
Discovering the peaks and valleys of Dare Bioscience, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 582.91%
Maximum Annual PE Ratio = -0.28
Minimum Annual Increase = -96.12%
Minimum Annual PE Ratio = -7.29
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.61 | -75.26% |
| 2024 | -6.50 | 582.91% |
| 2023 | -0.95 | -58.05% |
| 2022 | -2.27 | -28.91% |
| 2021 | -3.19 | 116.93% |
| 2020 | -1.47 | 64.31% |
| 2019 | -0.90 | 216.58% |
| 2018 | -0.28 | -96.12% |
| 2017 | -7.29 | 21.90% |
| 2016 | -5.98 | -72.27% |
The current PE Ratio of Dare Bioscience, Inc. (DARE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.02
5-year avg
-2.90
10-year avg
-3.04
Dare Bioscience, Inc.’s PE Ratio is less than FibroBiologics, Inc. Common Stock (-0.08), less than Citius Pharmaceuticals, Inc. (-0.22), greater than Leap Therapeutics, Inc. (-30.04), less than Ainos, Inc. (-0.46), less than Athira Pharma, Inc. (-0.23), less than Aspire Biopharma Holdings, Inc. (-0.67), less than Aditxt, Inc. (-0.00), greater than Palisade Bio, Inc. (-1.85), greater than Adlai Nortye Ltd. (-7.48), less than Hoth Therapeutics, Inc. (-0.94),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.08 | $1.37M | |
| -0.22 | $6.36M | |
| -30.04 | $31.86M | |
| -0.46 | $5.98M | |
| -0.23 | $26.62M | |
| -0.67 | $647.24K | |
| -0.00 | $2.69M | |
| -1.85 | $340.22M | |
| -7.48 | $642.80M | |
| -0.94 | $9.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dare Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dare Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Dare Bioscience, Inc.'s PE Ratio?
How is the PE Ratio calculated for Dare Bioscience, Inc. (DARE)?
What is the highest PE Ratio for Dare Bioscience, Inc. (DARE)?
What is the 3-year average PE Ratio for Dare Bioscience, Inc. (DARE)?
What is the 5-year average PE Ratio for Dare Bioscience, Inc. (DARE)?
How does the current PE Ratio for Dare Bioscience, Inc. (DARE) compare to its historical average?